✦ LIBER ✦

P78. NHS resource use and capacity planning in breast cancer patients with metastatic bone disease treated with IV zoledronic acid or oral ibandronic acid

✍ Scribed by Robert Grieve; Kate Peperell; Elizabeth Hamilton

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Renal function changes and resource use

✍ Stephen J. Houston; Robert J. Grieve; Fran Percival; Nicola J. Fisher; Liz Hamil 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 70 KB

Cost-effectiveness of oral ibandronate c

✍ E. Cock; J. Hutton; P. Canney; J. J. Body; P. Barrett-Lee; M. P. Neary; G. Lewis 📂 Article 📅 2005 🏛 Springer-Verlag 🌐 English ⚖ 200 KB

PCN5 BUDGET IMPACT ANALYSIS OF INTRAVENO

✍ M Botteman; M Aapro; J Stephens; JW Hay; J Brandman 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB

Time and costs associated with preparing

✍ Alan Oglesby; Bintu Sherif; Dawn Odom; Michael Leahy; Yi Qian 📂 Article 📅 2009 🏛 Frontline Medical Communications, Inc. 🌐 English ⚖ 104 KB